Zhejiang Ausun Pharmaceutical Co Ltd (603229) — Cash Flow-to-Debt Ratio
Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥121.49 Million could theoretically repay 0% of its total liabilities (CN¥713.05 Million) in one year. Check 603229 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Ausun Pharmaceutical Co Ltd across 14 annual periods. Also explore 603229 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Ausun Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 603229 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥156.51 Million | CN¥815.89 Million | ▼ -23.4% |
| 2024 | 0.25x | CN¥177.93 Million | CN¥710.50 Million | ▼ -8.6% |
| 2023 | 0.27x | CN¥221.85 Million | CN¥809.99 Million | ▲ +94.0% |
| 2022 | 0.14x | CN¥120.57 Million | CN¥854.19 Million | ▼ -52.5% |
| 2021 | 0.30x | CN¥173.90 Million | CN¥584.64 Million | ▼ -45.3% |
| 2020 | 0.54x | CN¥138.47 Million | CN¥254.81 Million | ▲ +49.3% |
| 2019 | 0.36x | CN¥87.73 Million | CN¥240.96 Million | ▲ +546.9% |
| 2018 | 0.06x | CN¥11.50 Million | CN¥204.38 Million | ▼ -78.7% |
| 2017 | 0.26x | CN¥46.78 Million | CN¥176.65 Million | ▼ -42.4% |
| 2016 | 0.46x | CN¥93.21 Million | CN¥202.76 Million | ▲ +83.3% |
| 2015 | 0.25x | CN¥53.63 Million | CN¥213.81 Million | ▲ +112.7% |
| 2014 | 0.12x | CN¥21.45 Million | CN¥181.90 Million | ▲ +9.4% |
| 2013 | 0.11x | CN¥15.73 Million | CN¥145.87 Million | ▲ +1163.0% |
| 2012 | -0.01x | CN¥-1.14 Million | CN¥112.21 Million | — |